Related Experiment Videos
The total condylar III knee prosthesis in elderly patients.
C H Kavolus1, P M Faris, M A Ritter
1Center for Hip and Knee Surgery, Mooresville, Indiana.
The Journal of Arthroplasty
|March 1, 1991
Summary
This study evaluated the Total Condylar III prosthesis in 16 knee replacements for patients aged 69+, finding 15 of 16 achieved good to excellent Hospital for Special Surgery (HSS) scores after 3-4.5 years.
Area of Science:
- Orthopedic Surgery
- Biomedical Engineering
- Geriatric Medicine
Background:
- Total knee arthroplasty (TKA) is a common procedure for end-stage knee osteoarthritis.
- Revision TKA presents unique challenges, particularly in elderly patients.
- The Total Condylar III prosthesis is designed for complex primary and revision knee arthroplasty cases.
Purpose of the Study:
- To evaluate the clinical outcomes of the Total Condylar III prosthesis in a cohort of elderly patients undergoing knee arthroplasty.
- To assess the efficacy of this prosthesis in both primary and revision TKA procedures within this demographic.
Main Methods:
- A retrospective review of 16 knee arthroplasties performed with the Total Condylar III prosthesis in 14 patients.
- Patients had an average age of 71 years, with most being 69 years or older.
- Follow-up averaged 4.5 years (minimum 3 years), with outcomes assessed using the Hospital for Special Surgery (HSS) knee score.
Main Results:
- Fifteen of sixteen implants (93.75%) achieved good to excellent HSS knee scores.
- The average patient age was 71 years, with a focus on the geriatric population (≥69 years).
- Eleven of the sixteen procedures were revision arthroplasties, indicating the prosthesis's utility in complex cases.
Conclusions:
- The Total Condylar III prosthesis demonstrates favorable clinical outcomes in elderly patients undergoing knee arthroplasty, including complex revision cases.
- High rates of good to excellent HSS scores suggest this implant is a viable option for improving function in this patient group.
- The prosthesis shows promise for managing degenerative knee conditions in older adults, potentially reducing pain and improving mobility.